Loss of Raf Kinase Inhibitor Protein Promotes Cell Proliferation and Migration of Human Hepatoma Cells
Open Access
- 31 October 2006
- journal article
- Published by Elsevier BV in Gastroenterology
- Vol. 131 (4), 1208-1217
- https://doi.org/10.1053/j.gastro.2006.07.012
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Pamidronate induced anti-proliferative, apoptotic, and anti-migratory effects in hepatocellular carcinomaJournal of Hepatology, 2006
- The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor proteinJournal of Cellular Biochemistry, 2005
- Role of Constitutively Activated and Insulin‐Like Growth Factor‐Stimulated ERK1/2 Signaling in Human Hepatoma Cell Proliferation and Apoptosis: Evidence for Heterogeneity of Tumor Cell LinesAnnals of the New York Academy of Sciences, 2004
- Raf kinase inhibitory protein inhibits β-cell proliferationSurgery, 2004
- Mitogen-Activated Protein Kinase Phosphatase-1 Is Overexpressed in Non-Small Cell Lung Cancer and Is an Independent Predictor of Outcome in PatientsClinical Cancer Research, 2004
- Crystal structures of YBHB and YBCL from Escherichia coli, two bacterial homologues to a Raf kinase inhibitor proteinJournal of Molecular Biology, 2001
- ACTIVATION OF EXTRACELLULAR SIGNAL-REGULATED KINASE IN HUMAN PROSTATE CANCERJournal of Urology, 1999
- Biological effects of human insulin receptor substrate-1 overexpression in hepatocytesHepatology, 1997
- Increased MAPK Expression and Activity in Primary Human Hepatocellular CarcinomaBiochemical and Biophysical Research Communications, 1997
- Insulin‐like growth factors I and IIEuropean Journal of Biochemistry, 1990